Intrinsic Type 1 Interferon (IFN1) Profile of Uncultured Human Bone Marrow CD45low CD271+ Multipotential Stromal Cells (BM-MSCs): The Impact of Donor Age, Culture Expansion and IFNα and IFNβ Stimulation

Biomedicines
Payal GangulyElena A Jones

Abstract

Skeletal aging is associated with reduced proliferative potential of bone marrow (BM) multipotential stromal cells (MSCs). Recent data suggest the involvement of type 1 interferon (IFN1) signalling in hematopoietic stem cell (HSC) senescence. Considering that BM-HSCs and BM-MSCs share the same BM niche, we investigated IFN1 expression profile in human BM-MSCs in relation to donor age, culture-expansion and IFN1 (α and β) stimulation. Fluorescence-activated cell sorting was used to purify uncultured BM-MSCs from younger (19-41, n = 6) and older (59-89, n = 6) donors based on the CD45lowCD271+ phenotype, and hematopoietic-lineage cells (BM-HLCs, CD45+CD271-) were used as controls. Gene expression was analysed using integrated circuits arrays in sorted fractions as well as cultured/stimulated BM-MSCs and Y201/Y202 immortalised cell lines. IFN1 stimulation led to BM-MSC growth arrest and upregulation of many IFN1-stimulated genes (ISGs), with IFNβ demonstrating stronger effects. Uncultured MSCs were characterised by a moderate-level ISG expression similar to Y201 cells. Age-related changes in ISG expression were negligible in BM-MSCs compared to BM-HLCs, and intracellular reactive oxygen species (ROS) levels in BM-MSCs did not sign...Continue Reading

References

Nov 30, 2005·Immunological Reviews·Hiroshi TakayanagiTadatsugu Taniguchi
Sep 19, 2006·Immunity·Jacques Banchereau, Virginia Pascual
May 4, 2007·Scandinavian Journal of Rheumatology·F DossB Müller
Apr 9, 2008·Archives of Biochemistry and Biophysics·Brendan F Boyce, Lianping Xing
May 10, 2008·Arthritis Research & Therapy·Joel A G van Roon, Floris P J G Lafeber
Aug 13, 2010·Nature·Simón Méndez-FerrerPaul S Frenette
Feb 22, 2011·Nature Cell Biology·Feng LiuJun Gu
Mar 15, 2011·Best Practice & Research. Clinical Haematology·Abhishek Harichandan, Hans-Jörg Bühring
May 23, 2012·Proceedings of the National Academy of Sciences of the United States of America·Eri Taniguchi IshikawaJose A Cancelas
Jun 12, 2013·Cell·Carlos López-OtínGuido Kroemer
Feb 22, 2014·Annual Review of Immunology·William M SchneiderCharles M Rice
Dec 9, 2014·Cell Cycle·Maggie PurcellMichael A Tainsky
Mar 12, 2015·Biological & Pharmaceutical Bulletin·Tomoharu TakeuchiYoichiro Arata
Aug 8, 2015·BioMed Research International·Rinaldo Florencio-SilvaPaulo Sérgio Cerri
May 5, 2016·Cellular and Molecular Life Sciences : CMLS·Miaohua MoYaojiong Wu
Oct 30, 2016·Trends in Endocrinology and Metabolism : TEM·Claudio FranceschiStefano Salvioli
Nov 4, 2016·Cell Death & Disease·Nadine HonkeKarl S Lang
Nov 30, 2016·Frontiers in Immunology·Larisa V KovtonyukHitoshi Takizawa
Jan 17, 2017·Seminars in Hematology·Wendy W PangIrving L Weissman
Mar 16, 2017·The Journal of Biological Chemistry·Gideon Schreiber
Mar 31, 2017·Cell Cycle·Atan GrossHans Joerg Fehling
Apr 27, 2017·Journal of Cellular and Molecular Medicine·Mustafa BecerikliBjörn Behr
Dec 19, 2017·Cell·Xianfang WuCharles M Rice
Dec 27, 2017·Progress in Biophysics and Molecular Biology·Adrian WeberChunyi Wen
Apr 7, 2018·The Journal of Experimental Medicine·Tuo Li, Zhijian J Chen
Aug 1, 2018·Trends in Molecular Medicine·Beiyun C LiuAlexander Poltorak
Jan 20, 2019·Bone·Joshua N Farr, Sundeep Khosla
Feb 8, 2019·Nature·Bennett Childs, Jan van Deursen

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
flow cytometry
FACS
enzyme-linked immunosorbent assay

Software Mentioned

GraphPad Prism
FACS Diva
Cluster
Treeview

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.